Sepoy-logo
No Result
View All Result
Tuesday, February 7, 2023
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
No Result
View All Result
SEPOY.NET
No Result
View All Result
Home Health

Study elucidates mechanism that is crucial for making hemophilia therapy effective

Nicholas by Nicholas
October 27, 2022
in Health
0

Hemophilia A is the most common severe form of hemophilia. It affects almost exclusively males. The disease can usually be treated well, but not for all sufferers. A study at the University of Bonn has now elucidated an important mechanism that is crucial for making the therapy effective. The results could help better tailor treatment to patients. They have already been published online in a preliminary version; the final version will soon be published in the “Journal of Clinical Investigation.”

Hemophilia A patients have a defect in a protein that is important for blood clotting: factor VIII. Most patients therefore receive an intravenous injection of the functional clotting factor every few days as treatment. But frequently, and especially at the start of treatment, the immune system recognizes the injected agent as foreign to the body and attacks it. This is the most serious complication of hemophilia treatment because factor VIII can then no longer work.

In these cases, immune tolerance therapy, which was also developed at the University Hospital Bonn (UKB) more than 40 years ago, often helps. This involves regularly injecting the hemophiliacs with a high dose of factor VIII over several months. The immune system thereby gets used to the injected protein and tolerates it. The underlying immune mechanisms are unknown.

However, this doesn’t always work. In about 30 percent of patients, tolerance induction does not lead to success. So your body’s own defenses continue to attack and destroy the factor VIII protein, which means that factor VIII cannot be used for treatment. We wanted to know the reason for this.”


Prof. Dr Johannes Oldenburg, Director of the Institute for Experimental Haematology and Transfusion Medicine, UKB

To this end, the team looked at two cell types in the immune system, B cells and regulatory T cells. B cells recognize foreign molecules in the body and produce antibodies against them, which switch off the function of the molecule. For factor VIII, this means that it is no longer effective in hemophilia treatment.

Brake in the immune system

Regulatory T cells prevent an immune response from being too strong or lasting too long. The researchers have now found a new type among them that can act specifically against certain B cells rather than just non-specifically against all immune responses. “We were able to show that immunotolerance therapy results in the generation of regulatory T cells that exclusively induce B cells against factor VIII to commit suicide,” says Dr.

Janine Becker-Gotot of the Institute of Molecular Medicine and Experimental Immunology (IMMEI) at UKB. “These T cells have a sensor that allows them to recognize and attach to the corresponding B cells. In addition, they have the ability to push the self-destruct button on the surface of B cells.”

This button is a molecule called PD-1. By activating it, it starts a program in the B cell that results in its death. Every active B cell has this button. “Our experiments enabled us for the first time to detect regulatory T cells that can activate this self-destruct button only in very specific B cells, in order to specifically prevent unwanted immune responses,” explains IMMEI Director Prof. Dr. Christian Kurts.

The more PD-1 buttons the B cells against factor VIII carry on their surface, the easier it is for them to be driven to suicide by immune tolerance therapy. “The amount of PD-1 varies from person to person,”

Becker-Gotot explains. “If it’s very low to begin with, there’s a good chance that many inhibitor-producing B cells will survive and continue to neutralize the injected factor VIII.”

Test to show in whom immunotolerance therapy is useful

Interestingly, B cells also produce more PD-1 once they come into contact with regulatory T cells. “We can now test how strong this reaction is,” the researcher says. “If PD-1 levels go up shortly after starting immune tolerance therapy and then stay up, that’s a clear sign that the treatment is going to be successful.” The team is currently developing a blood test that can be used to detect whether or not immune tolerance therapy is working in patients during the prolonged treatment.

“Our findings have great basic scientific value,” explains Prof. Kurts, who is a member of the Transdisciplinary Research Area “Life & Health” at the University of Bonn and, like Dr. Becker-Gotot and Prof. Oldenburg, a member of the Cluster of Excellence ImmunoSensation. “And not just for hemophilia, but also for other congenital disorders where missing proteins are replaced therapeutically. In the long term, they could also be used to develop new treatments.”

Participating institutions and funding:

In addition to the IMMEI and the Institute of Experimental Haematology and Transfusion Medicine at the University Hospital Bonn, the IMC University of Applied Sciences in Krems (Austria) and the University of Melbourne

(Australia) were involved in the study. The work was funded by the German Research Foundation (DFG), the University Hospital Bonn (Bonfor), a joint graduate college of the Universities of Bonn and Melbourne, the German National Academic Foundation (Studienstiftung des Deutschen Volkes) and the European “Innovative Medicines Initiative” (IMI).

Source:

Journal reference:

Becker-Gotot, J., et al. (2022) Immune tolerance against infused FVIII in hemophilia A is mediated by PD-L1+ regulatory T cells. The Journal of Clinical Investigation. doi.org/10.1172/JCI159925.

Source

READ ALSO

Development and testing of a machine-learning-based system for early prediction of antimicrobial susceptibility probability

VUMC’s Shed-MEDS protocol reduces exposure to potentially inappropriate medications

Tags: B CellBeckerBloodCellHaematologyHemophiliaHemophilia AHospitalImmune SystemMedicineMoleculeProteinResearch

Related Posts

Development and testing of a machine-learning-based system for early prediction of antimicrobial susceptibility probability
Health

Development and testing of a machine-learning-based system for early prediction of antimicrobial susceptibility probability

February 7, 2023
VUMC’s Shed-MEDS protocol reduces exposure to potentially inappropriate medications
Health

VUMC’s Shed-MEDS protocol reduces exposure to potentially inappropriate medications

February 7, 2023
How did human mobility affect COVID-19 case growth?
Health

How did human mobility affect COVID-19 case growth?

February 6, 2023
AAHI awarded a .9 million project to develop prototype intranasal bivalent influenza RNA vaccine candidate
Health

AAHI awarded a $9.9 million project to develop prototype intranasal bivalent influenza RNA vaccine candidate

February 6, 2023
Why two states remain holdouts on distracted driving laws
Health

Why two states remain holdouts on distracted driving laws

February 6, 2023
Virus Watch: A cohort study of COVID-19 in households of England and Wales
Health

Virus Watch: A cohort study of COVID-19 in households of England and Wales

February 6, 2023
Next Post

Incitement of the people: Tightening of the law in a hurry

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

POPULAR NEWS

Roblox Is Unbreakable Trello Is this safe?

Roblox Is Unbreakable Trello Is this safe?

November 4, 2022
Discord Registered Games  Discord Registered Gaming You need to join the Club

Discord Registered Games Discord Registered Gaming You need to join the Club

November 4, 2022
How To Chose the Right Data Analytics Program

How To Chose the Right Data Analytics Program

November 4, 2022
Chandrashekhar Guruji Wiki, Age, Girlfriend, Wife, Family, Biography & More

Chandrashekhar Guruji Wiki, Age, Girlfriend, Wife, Family, Biography & More

November 4, 2022
Heavy explosion on market square in Halle – three injured

Heavy explosion on market square in Halle – three injured

November 4, 2022

EDITOR'S PICK

Curb in Rüsselsheim: car drives in a group of revelers – six injured

September 24, 2022
What is a modular blockchain?

What is a modular blockchain?

January 21, 2023
Vitamin D can help the immune system fight tuberculosis, study says

Vitamin D can help the immune system fight tuberculosis, study says

January 6, 2023

What are the Product Owner’s responsibilities?

October 19, 2022

About

Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.

Contact: [email protected]

Major Categories

News

Business

Tech

Economy

 

Recent Posts

  • Development and testing of a machine-learning-based system for early prediction of antimicrobial susceptibility probability
  • Inflation in Argentina: a new 2000 peso note had to be created
  • Earthquake death toll rises to more than 4,200

Pages

  • About Us
  • Contact Us
  • Disclaimer
  • DMCA
  • Home
  • Privacy Policy

© 2023 Sepoy.net

No Result
View All Result
  • Home
  • Business
  • News
  • Health
  • Tech
  • Science
  • Lifestyle
  • Travel

© 2023 Sepoy.net